José Colleti Júnior1, Atsushi Kawaguchi2, Orlei Ribeiro de Araujo3, Daniel Garros4. 1. Unidade de Terapia Intensiva Pediátrica, Hospital Santa Catarina - São Paulo (SP), Brasil. 2. Departamento de Pediatria, Universidade de Montreal, CHU Sainte-Justine - Montreal, QC, Canadá. 3. Grupo de Apoio ao Adolescente e à Criança com Câncer, Instituto de Oncologia Pediátrica, Universidade Federal de São Paulo - São Paulo (SP), Brasil. 4. Departamento de Pediatria, Division of Critical Care, Stollery Children's Hospital, University of Alberta - Edmonton, AB, Canadá.
Abstract
OBJECTIVE: To describe current clinical practices related to the use of high-flow nasal cannula therapy by Brazilian pediatric intensivists and compare them with those in other countries. METHODS: A questionnaire was administered to pediatric intensivists in North and South America, Asia, Europe, and Australia/New Zealand for the main study. We compared the Brazilian cohort with cohorts in the United States of America, Canada, the United Kingdom, and India. RESULTS: Overall, 501 physicians responded, 127 of which were in Brazil. Only 63.8% of respondents in Brazil had a high-flow nasal cannula available, in contrast to 100% of respondents in the United Kingdom, Canada, and the United States. The attending physician was responsible for the decision to start a high-flow nasal cannula according to 61.2% respondents in Brazil, 95.5% in the United Kingdom, 96.6% in the United States, 96.8% in Canada, and 84.7% in India. A total of 62% of respondents in Brazil, 96.3% in the United Kingdom, 96.6% in the United States, 96.8% in Canada, and 84.7% in India reported that the attending physician was responsible for the decision to wean or modify the high-flow nasal cannula settings. When high-flow nasal cannula therapy failed due to respiratory distress/failure, 82% of respondents in Brazil would consider a trial of noninvasive ventilation before endotracheal intubation, compared to 93% in the United Kingdom, 88% in the United States, 91.5% in Canada, and 76.8% in India. More Brazilian intensivists (6.5%) than intensivists in the United Kingdom, United States, and India (1.6% for all) affirmed using sedatives frequently with high-flow nasal cannulas. CONCLUSION: The availability of high-flow nasal cannulas in Brazil is still not widespread. There are some divergences in clinical practices between Brazilian intensivists and their colleagues abroad, mainly in processes and decision-making about starting and weaning high-flow nasal cannula therapy.
OBJECTIVE: To describe current clinical practices related to the use of high-flow nasal cannula therapy by Brazilian pediatric intensivists and compare them with those in other countries. METHODS: A questionnaire was administered to pediatric intensivists in North and South America, Asia, Europe, and Australia/New Zealand for the main study. We compared the Brazilian cohort with cohorts in the United States of America, Canada, the United Kingdom, and India. RESULTS: Overall, 501 physicians responded, 127 of which were in Brazil. Only 63.8% of respondents in Brazil had a high-flow nasal cannula available, in contrast to 100% of respondents in the United Kingdom, Canada, and the United States. The attending physician was responsible for the decision to start a high-flow nasal cannula according to 61.2% respondents in Brazil, 95.5% in the United Kingdom, 96.6% in the United States, 96.8% in Canada, and 84.7% in India. A total of 62% of respondents in Brazil, 96.3% in the United Kingdom, 96.6% in the United States, 96.8% in Canada, and 84.7% in India reported that the attending physician was responsible for the decision to wean or modify the high-flow nasal cannula settings. When high-flow nasal cannula therapy failed due to respiratory distress/failure, 82% of respondents in Brazil would consider a trial of noninvasive ventilation before endotracheal intubation, compared to 93% in the United Kingdom, 88% in the United States, 91.5% in Canada, and 76.8% in India. More Brazilian intensivists (6.5%) than intensivists in the United Kingdom, United States, and India (1.6% for all) affirmed using sedatives frequently with high-flow nasal cannulas. CONCLUSION: The availability of high-flow nasal cannulas in Brazil is still not widespread. There are some divergences in clinical practices between Brazilian intensivists and their colleagues abroad, mainly in processes and decision-making about starting and weaning high-flow nasal cannula therapy.
Authors: Sarah Rubin; Anoopindar Ghuman; Timothy Deakers; Robinder Khemani; Patrick Ross; Christopher J Newth Journal: Pediatr Crit Care Med Date: 2014-01 Impact factor: 3.624
Authors: Thomas Weiler; Asavari Kamerkar; Justin Hotz; Patrick A Ross; Christopher J L Newth; Robinder G Khemani Journal: J Pediatr Date: 2017-06-29 Impact factor: 4.406
Authors: Kristen D Coletti; Dayanand N Bagdure; Linda K Walker; Kenneth E Remy; Jason W Custer Journal: Respir Care Date: 2017-06-06 Impact factor: 2.258
Authors: Amélie O Von Saint André-Von Arnim; Bob Okeyo; Nathan Cook; Mardi Steere; Joan Roberts; Christopher R A Howard; Larissa I Stanberry; Grace C John-Stewart; Arianna Shirk Journal: Paediatr Int Child Health Date: 2018-11-19 Impact factor: 1.990